Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02250950 · ClinicalTrials.gov registry record · Phase 2

An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention

A Phase 2 study of Exercise Promotion, sponsored by Syracuse University.

Completed
Registry status
Phase 2
Development phase
57
Enrollment target
1
Study location

NCT02250950: Completed Phase 2 study of Exercise Promotion, sponsored by Syracuse University.

NCT02250950 is a Phase 2 study of Exercise Promotion that has completed, run by Syracuse University. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02250950, a Phase 2 study of Exercise Promotion, has completed, sponsored by Syracuse University.

COMPLETED
Registry status
Phase 2
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The current study involves conducting an intervention based on self-determination theory (SDT) and motivational interviewing (MI) to promote physical activity in a racially-diverse sample. It is expected that this intervention will successfully increase physical activity in participants.

Conditions Studied

Interventions

  • BEHAVIORAL MI and SDT Exercise Group
  • BEHAVIORAL Non-MI and SDT Exercise Group

Study Locations (1)

New York

  • Lauren S. Miller - Guilderland

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2014-06
Est. Completion 2015-02
Phase Phase 2

Sponsor

Syracuse University

31 total trials

What the Registry Record Tells You About NCT02250950

The ClinicalTrials.gov registry entry for NCT02250950 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Exercise Promotion appearing as the primary indexed condition, and to 2 interventions - of which MI and SDT Exercise Group is the first listed.

NCT02250950 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02250950 about?

NCT02250950 is a clinical study titled "An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention". The current study involves conducting an intervention based on self-determination theory (SDT) and motivational interviewing (MI) to promote physical activity in a racially-diverse sample. It is expected that this intervention will successfully increase physical activity in participants.

What is the current status of trial NCT02250950?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2014-06. Estimated completion is 2015-02.

What conditions does trial NCT02250950 study?

This clinical trial studies the following conditions: Exercise Promotion.

What interventions are being tested in trial NCT02250950?

The interventions under investigation include: MI and SDT Exercise Group (BEHAVIORAL), Non-MI and SDT Exercise Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02250950?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02250950 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.